Wellness Health Group, LLC

Wellness Health Group, LLC was paid $727K by Medicaid between Apr 2019 and Dec 2024, across 62 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 39% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Oklahoma

Rank by total paid#16 of 46

Median peer was paid$248K

This provider vs. median2.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	1,088	$29K
2020	2,759	$139K
2021	3,409	$119K
2022	10,196	$285K
2023	14,810	$95K
2024incomplete	5,728	$59K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	39%	3,830	1,590	$284K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	16%	2,656	2,504	$119K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	12%	917	869	$84K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	8.2%	2,558	1,093	$59K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	5.3%	1,137	1,026	$39K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	4.5%	701	566	$32K
87500		2.5%	1,321	1,189	$18K
80050	General health panel	1.5%	389	377	$11K
80053	Comprehensive metabolic panel	<1%	1,998	1,734	$7K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	2,234	1,860	$6K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	428	373	$6K
80061	Lipid panel	<1%	1,428	1,293	$6K

50 more codes

87640		<1%	939	$6K
87150		<1%	746	$5K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,541	$5K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	896	$5K
87641		<1%	895	$5K
87581		<1%	830	$4K
87541		<1%	808	$3K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	13	$3K
87481		<1%	245	$2K
84481		<1%	550	$2K
87486		<1%	405	$2K
87551		<1%	195	$1K
86376		<1%	154	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	212	$1K
84439		<1%	732	$1K
84443	Thyroid stimulating hormone (TSH)	<1%	948	$1K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	197	$1K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	182	$986.91
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	782	$946.75
80048	Basic metabolic panel (calcium, ionized)	<1%	228	$714.24
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	329	$543.69
84134		<1%	61	$480.26
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	120	$407.57
36415	Collection of venous blood by venipuncture	<1%	2,035	$327.56
82728		<1%	166	$290.88
80177		<1%	27	$259.38
83550		<1%	260	$202.99
83880		<1%	14	$174.60
81003		<1%	318	$168.60
80164		<1%	25	$144.48
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	991	$136.91
82607		<1%	458	$113.43
83735		<1%	461	$110.10
87086	Culture, bacterial; quantitative colony count, urine	<1%	157	$95.12
87511		<1%	56	$70.18
86140		<1%	16	$69.15
85652		<1%	28	$64.80
83540		<1%	54	$46.00
87186		<1%	86	$39.41
87077		<1%	86	$36.86
87653		<1%	156	$35.09
82746		<1%	120	$29.40
80076		<1%	12	$15.44
84100		<1%	192	$9.39
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	578	$7.82
83719		0%	14	$0.00
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	0%	15	$0.00
81405		0%	31	$0.00
83695		0%	14	$0.00
82248		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLOUDERMILK, DENNIS (CEO)